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Survival in critical illness depends on the adequate adrenocortical function. The levels of plasma cortisol are elevated in the majority of critically ill patients. 
Increased release of cortisol from the adrenal cortex during 
severe illness and stress reflects the enhanced activity of the 
hypothalamic‑pituitary‑adrenal axis (HPA) [1,2]. However, in 
many patients who are critically ill, there may be impaired 
homeostasis and adaptation [3]. These patients have an 
inadequate production of cortisol leading to relative or 
functional adrenal insufficiency (AI) in relation to increased 
demand during periods of severe stress. AI is a clinical 
condition associated with hypotension that can be resistant to 
fluid and catecholamine therapy and, if untreated, can result 
in increased mortality [4‑6]. The larger fluid volumes needed 
to be given as well as the greater need for catecholamines 
in patients with unrecognized AI may result in a longer 
requirement for mechanical ventilation [7,8] and a prolonged 
need for invasive monitoring and vascular access in adult 
patients [8].
Multiple different definitions were used for the diagnosis 
of AI in many pediatric studies, focused almost exclusively on 
patients with septic shock [9‑19], did not conduct corticotropin 
stimulation tests on all patients (only obtained random cortisol 
levels) [20‑22], and used different doses for the corticotropin 
tests [11,14,15,19,22]. As a result, the reported prevalence of AI 
varies from 10% to 100% [21,22]. Very few studies identified 
risk factors for the development of AI and were adequately 
powered to assess associations with outcomes or studied both 
the high‑ and low‑dose corticotropin tests [9,23]. Furthermore, 
the majority of studies did not measure adrenocorticotropic 
hormone (ACTH) levels [11,12,15,16].
The term “critical illness‑related corticosteroid 
insufficiency (CIRCI)” was introduced recently [24]. 
Recommendations for the diagnosis and management of this 
condition in adults were published by an international task 
force of the American College of Critical Care Medicine and 
have asked to avoid the term “relative AI” [25]. However, there 
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is less agreement regarding diagnostic criteria and prevalence 
of this condition among intensivists and endocrinologists in the 
pediatric population [26].
The objectives of this study were to determine prospectively 
the incidence of CIRCI, risk factors, mechanisms for its 
development and association with clinically important 
outcomes using ACTH stimulation test in critically ill children
MATERIALS AND METHODS
This study was conducted as a prospective single‑center cohort 
study in the pediatric intensive care unit (PICU) of a tertiary 
care teaching hospital, over a period of 1 year from August 
2012 to July 2013. Patients were eligible if they were 1 month 
to 17 years of age and had arterial or central venous catheter 
and enrolled within 24 h of admission. Neonates and patients 
with known or suspected adrenal, pituitary or hypothalamic 
disease, patients who had received systemic steroid for more 
than 10 days in previous month or had more than one dose of 
systemic steroid within 24 h before admission and those who 
were expected to have care withdrawn or were transferred 
from another ICU were excluded from the study. Suspected 
or diagnosed cases of asthma or allergic diseases were also 
excluded. None of the patients received etomidate. Approval 
from research ethics committee of the hospital was obtained. 
Written informed consent was obtained from all parents of 
study participants just after admission in PICU.
Random serum total cortisol, ACTH, glucose, and 
electrolytes were measured for all the patients after enrollment. 
Patients were given 250 µg of cosyntropin (Cortrosyn, Mylan 
Institutional LLC‑Gland Pharma, India) intravenously with 
a repeat cortisol level measured at 30 min. This ACTH 
stimulation test was performed within 1 h after admission. After 
centrifugation, samples were preserved within ice packs in PICU 
and were transported to the central lab with ice packs. In lab, 
they were stored at −20°C in the deep freezer before processing. 
Plasma cortisol levels were measured using chemiluminescence 
immunoassay (Unicel Dxl 600) (measurement range: 
0.4‑60 µg/dl, coefficient of variation: Kit insert CV% 7.9%), 
and serum ACTH were measured using chemiluminescence 
immunoassay (Immulite 2000 xpi) (measurement range: 
5‑1250 pg/ml, coefficient of variation: Kit insert CV% 10%).
CIRCI was defined as an increment in serum total 
cortisol (delta cortisol) ≤9 µg/dl after ACTH stimulation 
test as recommended by consensus statements from 
international task force by American College of Critical Care 
Medicine 2008 [25]. We documented baseline characteristics 
including diagnosis, age, and the pediatric risk of mortality 
score (PRISM‑III) [27] in all patients. PRISM‑III score 
was calculated using an online calculator. Institutional 
protocols were used for treating all patients admitted to PICU 
independent of study participation. The treating PICU team 
was kept unaware of the results of cortisol and ACTH so as 
not to influence the patient’s treatment.
Fluid boluses were calculated from the arrival time in PICU. 
The amount of fluid used for the resuscitation in the emergency 
room (20‑40 ml/kg) before shifting to PICU was not included, and 
requirement of only additional fluid boluses received in PICU was 
correlated. Furthermore, fluids given after ACTH test were not 
included as it was not part of the study. These fluid boluses were apart 
from the maintenance fluids, replacement fluids, or medications. 
As a protocol of this study, we have calculated only number of 
catecholamines used (dopamine, dobutamine, noradrenaline, and 
adrenaline) and not their mean doses. Catecholamines were chosen 
and added in a graded fashion depending on the type and severity 
of shock. If one drug at maximum dose was not able to correct 
hypotension, second or third drug was added. Higher number of 
catecholamines suggests more severe hypotension.
The primary objective of this study was to determine 
the incidence of CIRCI on the day of admission. Secondary 
objectives were to identify possible risk factors for CIRCI, 
including age, diagnosis, and severity of illness, to determine 
the association of CIRCI with the need of catecholamines, fluid 
boluses, and PICU mortality.
Statistical analysis was made with IBM SPSS 19.0 version. 
Data were expressed as median (range) or mean (±standard 
deviation) according to data distribution. Patients were grouped 
according to presence or absence of CIRCI. Mann–Whitney 
U‑test or Student’s t‑test for continuous variables while Fisher’s 
exact test for categorical variables was used to compare two 
groups. Cortisol concentrations at baseline and after ACTH 
stimulation test were compared by paired t‑test. Associations 
between variables were assessed by Spearman’s correlation 
test. After determination of association of individual factors 
with CIRCI by univariate analysis, a binary logistic regression 
model of significant factors was developed. The results of 
regression model were presented as adjusted odds ratio. Wald’s 
Chi‑square value was used to test unique contribution of each 
predictor. p<0.05 was considered significant.
RESULTS
During the study period of 1 year, total 268 children were admitted 
to the PICU. Eligibility criteria were met by 158 (58.9%) 
patients. Of those 110 excluded patients, 39 (35.5%) patients 
had received more than one dose of steroid within the previous 
24 h (reasons for steroid use were not recorded), 31 (28.2%) had 
received more than 10 days of systemic steroid in the previous 
month, 24 (21.8%) expired within 24 h, and 16 (14.5%) were 
either referred to other center or discharged against medical 
advice. Of the eligible patients, in 21 (13.3%) consent could not 
be obtained in time and 23 (14.55%) had parents or guardian 
who declined consent. Finally, remaining 110 (42.6%) patients 
were enrolled in the study.
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For the given effect size population, mean of basal 
cortisol (27.37±11.64 vs. 22.02±7.26), sample size (42 and 68), 
and alpha (0.05, two‑tailed) statistical power was 0.84. Overall 
patient cohort had median age of 30 months (interquartile 
range [IQR], 1.5‑156.0), median weight 11 kg (IQR, 2‑32), 
69.1% were male and on admission, median PRISM score of 
17 (IQR, 11‑23). On the day of admission, 42 (38.2%) had 
CIRCI using ACTH stimulation test. Baseline characteristics 
between patients with or without CIRCI are shown in 
Table 1. Patients with CIRCI had significantly higher median 
age (34 vs. 18 months) and higher PRISM score (17.79±2.60 vs. 
16.37±3.68) (Table 1). The prevalence of CIRCI was 
highest (30.9%) in patients with septic shock followed by 
21.4% in patients with acute lung injury or acute respiratory 
distress syndrome (ALI/ARDS) (Table 2).
The baseline cortisol and corresponding ACTH levels in 
patients with CIRCI are shown in (Table 3). 3 (7.1%) of CIRCI 
patients had baseline cortisol levels >36 µg/dl and high ACTH 
levels. Almost 16.7% (7/42) of patients had very low baseline 
Table 1: Comparative demography and clinical 






Age in months, 
median (IQR)
34 (1.5‑156) 18 (2‑144) 0.0258
Weight in kg, 
median (IQR)
12 (2‑32) 11 (2.5‑27) 0.267






3.2 (1.9‑3.9) 3.1 (2.1‑3.9) 0.82
PRISM: Pediatric risk of mortality, IQR: Interquartile 
range, SD: Standard deviation, CIRCI: Critical 
illness-related corticosteroid insufficiency
Table 2: Distribution of study population according to 
primary systemic diagnosis





Status epilepticus 4 (1)* 10 0.567
Head injury 3 (1)* 13 0.101
Congestive cardiac failure 4 (1)* 4 (1)* 0.478
Severe gastroenteritis 3 (1)* 7 0.739
Acute liver failure 3 (2)* 1 (1)* 0.155
ALI/ARDS 9 (5)* 8 0.186
Poisoning/bites 3 (1)* 5 1.000
Septic shock 13 (10)* 10 (4)* 0.054
*Indicates number of deaths, ALI: Acute lung 
injury, ARDS: Acute respiratory distress syndrome, 
CIRCI: Critical illness-related corticosteroid insufficiency
Table 3: Basal cortisol and ACTH levels in patients with 
adrenal insufficiency
ACTH (pg/dl) Cortisol (µg/dl)
<18 18.1-36 >36.1
Low (<5.9) 1 1 0
Normal (6‑56.7) 6 13 12
High (>56.8) 1 5 3
ACTH: Adrenocorticotropic hormone












Cortisol (∆) level 
(mg/dl)
5.19±2.85 31.76±79.59 0.008
ACTH levels (pg/dl) 29.18±15.52 28.37±8.23 0.725
ACTH: Adrenocorticotropic hormone, CIRCI: Critical 
illness-related corticosteroid insufficiency
cortisol levels (<18 µg/dl) and normal or high ACTH levels 
suggestive of primary adrenal dysfunction, while majority 
61.9% (26/42) of the patients had normal to high cortisol with 
low or normal ACTH levels suggestive of secondary adrenal 
dysfunction.
The distribution of serum cortisol levels, pre‑ and 
post‑ACTH stimulation, is provided in Table 4. Basal 
cortisol levels (27.37±11.64 vs. 22.02±7.26) were 
significantly (p=0.004) higher while post‑ACTH stimulation 
cortisol levels (32.55±12.26 vs. 52.94±77.23) and cortisol 
increment (∆) levels (5.19±2.85 vs. 31.76±79.59) were 
significantly lower in patients with CIRCI. There was no 
significant difference in basal ACTH levels between the two 
groups (Table 4). The requirement of ventilation (46.6% 
vs. 53.4%) and duration of ventilation (56.27±19.53 vs. 
59.95±23.51) in two groups were not significantly different 
(Table 5). There was significantly higher (p=0.000) requirement 
of catecholamines (as shown by number of catecholamines 
used) (2.71±0.457 vs. 2.00±0.792) and extra fluid boluses 
in PICU (15.79±4.7 vs. 10.65±4.60) in patients with CIRCI 
but the duration of catecholamine use was not significantly 
different between two groups (Table 5).
Although mortality (52.3% vs. 7.8%) in CIRCI group was 
significantly higher (p=0.000), the duration of PICU stay 
did not differ from that of the other group. In the regression 
analysis, age, disease severity measured by PRISM score, and 
duration of catecholamine use were not found to be independent 
risk factors for CIRCI; however, use of higher number of 
additional fluid boluses (p=0.002) and higher number of 
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catecholamines (p=0.003) had independently increased the 
risk of CIRCI. For each additional use of catecholamine, the 
risk of CIRCI increased to 5.6 times; and for each extra fluid 
bolus, the risk increased to 1.2 times (Table 6). The presence 
of CIRCI was not found to be an independent risk factor for 
mortality.
DISCUSSION
In this single center prospective study, the incidence of CIRCI 
by definition of cortisol increment <9 µg/dl after ACTH 
stimulation was 38.18%. This incidence was consistent with 
prior studies [9,11,13,18,21,22] by similar definition of AI. 
Age, sex, weight, and disease severity were not found to be 
independent risk factors for the development of CIRCI. There 
was no significant difference in the incidence of CIRCI related 
to any specific disease condition. Despite of long standing 
focus in the literature on adrenal function in sepsis [12,15‑18], 
we could not find the increased risk of CIRCI in the presence 
of sepsis. Menon et al. and Balbão et al. also had similar 
observations [9,28].
The CIRCI was associated with more use of 
catecholamine (odds ratio 5.565, p=0.003) and higher additional 
fluid boluses (odds ratio 1.216, p=0.002) independently. 
Similar findings were observed by Menon et al. [9]; however, 
Balbão et al. [28] could not find such association. High 
mortality in our study population can be contributed by higher 
PRSIM score. Although mortality in children with CIRCI was 
significantly higher, CIRCI was not found to be an independent 
risk factor for mortality. This finding was consistent with prior 
studies [9,13,23,28].
Many factors lead to dysfunction of the HPA axis 
during illness. These include a decreased production of the 
corticotropin‑releasing hormone, ACTH and cortisol and 
dysfunction of their receptors. Some patients may have 
structural damage and peripheral resistance to glucocorticoids 
can also aggravate an inadequate response of the HPA axis 
to stress [21,23]. The decreased activity of glucocorticoids is 
probably caused by different interacting mechanisms. Of them, 
one is a reduction of glucocorticoid receptors [29] and the other, 
an increase in the conversion of cortisol to inactive cortisone 
by enhanced activity of 11‑β‑hydroxysteroid dehydrogenase 
stimulated by interleukin(IL)2, IL4, and IL13 [30].
Our study suggests that the mechanism for adrenal 
dysfunction in critically ill children may be highly variable and 
multifactorial. Many threshold levels for random cortisol in 
acute illness were proposed, but none was satisfactory. We have 
chosen the cutoff values, which were used in past studies by 
Menon et al. and Cooper and Stewart [26,31]. In the majority 
of patients with CIRCI, baseline cortisol levels were >18 µg/dl 
but did not increase with exogenous ACTH stimulation. This 
finding was consistent with prior studies. This may be because 
of the inability of adrenal gland to mount an adequate response 
despite a normal baseline cortisol levels during critical illness, 
or the definition of CIRCI may be simply a marker of the 
need for catecholamine and fluid or a reflection of end organ 
resistance [31,32] in critically ill children.
Almost 30% (14/42) of our CIRCI patients had baseline 
cortisol levels between 18 µg/dl and 36 µg/dl and inappropriately 
normal or low ACTH levels suggestive of HPA axis dysfunction. 
Although patients with baseline cortisol levels >36 mg/dl may 
still have dysfunction of HPA axis, they may not respond to 
exogenous glucocorticosteroids as plasma cortisol levels 
achieved by 1‑2 mg/kg of exogenous hydrocortisone may 
not be significantly higher than those already present in these 
patients [33]. There are no large randomized controlled trials on 
the use of steroid in critically ill children, yet many intensivists 
report using steroid to treat catecholamine and fluid‑resistant 
shock [25], and steroids have been recommended in the 
guidelines for the treatment of catecholamine‑resistant shock in 
children [34]. We have studied cortisol levels only on day 1 and 
follow‑up levels during further hospital stay were not studied, 
so it is beyond the scope of this study to comment whether 





















Length of PICU 
stay in days
68.90±18.63 67.17±25.43 0.652
Mortality n (%) 22 (52.3) 6 (7.8) 0.000
ACTH: Adrenocorticotropic hormone, CIRCI: Critical 
illness-related corticosteroid insufficiency, 
PICU: Pediatric intensive care unit
Table 6: Multivariate analysis of factors associated with 
CIRCI by logistic regression
Variable Wald df p value Odds ratio
Age 0.08 1 0.928 0.999
PRISM score 1.295 1 0.255 0.864
Duration of catecholamine 
use
0.102 1 0.749 1.002
Additional fluid boluses 9.687 1 0.002 1.216
Number of catecholamines 9.131 1 0.003 5.565
PRISM: Pediatric risk of mortality, df: Degree of 
freedom, CIRCI: Critical illness-related corticosteroid 
insufficiency
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these children with CIRCI would have been helped for their 
better outcome.
This study has many strength. To the best of our knowledge, 
this is the only Indian critical care trial to examine the incidence 
of AI in a wide spectrum of diseases. Furthermore, it is the only 
Indian study to explore the potential mechanisms of CIRCI in 
the critically ill population using ACTH stimulation testing 
as well as measurement of ACTH levels. The majority of our 
patients had secondary AI or HPA axis suppression and very 
few had primary AI. A potential limitation of our study is that 
we have not measured free cortisol levels. Serum albumin levels 
were comparable between children with or without CIRCI. The 
increment in cortisol level is independent of serum protein 
levels, and free cortisol measurements are available only in 
research laboratories, thereby limiting their usefulness. This 
study included only patients with existing vascular access and 
likely represents sicker children within the PICU. However, the 
clinical significance of this fact is unclear as disease severity 
was not found to be associated with CIRCI [9,12,21].
CONCLUSION
CIRCI occurs in a wide spectrum of diseases in critically ill 
children associated with increased need for catecholamine 
and fluids. CIRCI is likely to be multifactorial in etiology 
and associated with high basal cortisol. Further research is 
necessary to determine which of these critically ill children are 
truly cortisol deficient and who will be benefited by exogenous 
steroids.
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